Get all your news in one place
100’s of premium titles. One news app. Zero ads. Just $10 per month.

Where Illumina Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 1 3 0 0
Last 30D 0 0 1 0 0
1M Ago 0 0 1 0 0
2M Ago 0 0 0 0 0
3M Ago 0 1 1 0 0

In the last 3 months, 4 analysts have offered 12-month price targets for Illumina. The company has an average price target of $383.75 with a high of $460.00 and a low of $325.00.

Below is a summary of how these 4 analysts rated Illumina over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average represents a 9.97% decrease from the previous average price target of $426.25.

How Are Analyst Ratings Determined?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Related Stories
Where Zymeworks Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Zymeworks (NYSE:ZYME) stock. These analysts are typically employed…
One subscription that gives you access to news from hundreds of sites
Where Zynga Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Zynga (NASDAQ:ZNGA) stock. These analysts are typically employed…
Where Coty Stands With Analysts
Over the past 3 months, 5 analysts have published their opinion on Coty (NYSE:COTY) stock. These analysts are typically employed…
Where Lowe's Companies Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Lowe's Companies (NYSE:LOW) stock. These analysts are typically…
Where Autoliv Stands With Analysts
Over the past 3 months, 11 analysts have published their opinion on Autoliv (NYSE:ALV) stock. These analysts are typically employed…
One subscription that gives you access to news from hundreds of sites
Where Agree Realty Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Agree Realty (NYSE:ADC) stock. These analysts are typically…